ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30 2023 | Benzinga
PORTLAND, Maine, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended September 30, 2023 after the market closes on Monday, November 13, 2023.
The Company expects to file its Quarterly Report on Form 10-Q after the market closes on Monday, November 13, 2023. The Company anticipates no change to the preliminary sales results for the third quarter of 2023 that were disclosed on October ...